HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression.

Abstract
The development of immune checkpoint blockade therapy based on programmed cell death-protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) has revolutionized cancer therapies in recent years. However, only a fraction of patients responds to PD-1/PD-L1 inhibitors, owing to the heterogeneous expression of PD-L1 in tumor cells. This heterogeneity presents a challenge in the precise detection of tumor cells by the commonly used immunohistochemistry (IHC) approach. This situation calls for better methods to stratify patients who will benefit from immune checkpoint blockade therapy, to improve treatment efficacy. Positron emission tomography (PET) enables real-time visualization of the whole-body PD-L1 expression in a noninvasive way. Therefore, there is a need for the development of radiolabeled tracers to detect PD-L1 distribution in tumors through PET imaging. Compared to their L-counterparts, dextrorotary (D)-peptides have properties such as proteolytic resistance and remarkably prolonged metabolic half-lives. This study designed a new method to detect PD-L1 expression based on PET imaging of 68Ga-labeled PD-L1-targeted D-peptide, a D-dodecapeptide antagonist (DPA), in tumor-bearing mice. The results showed that the [68Ga]DPA can specifically bind to PD-L1-overexpressing tumors in vivo, and showed favorable stability as well as excellent imaging ability, suggesting that [68Ga]DPA-PET is a promising approach for the assessment of PD-L1 status in tumors.
AuthorsLulu Zhang, Siqi Zhang, Wenyu Wu, Xingkai Wang, Jieting Shen, Dongyuan Wang, Kuan Hu, Ming-Rong Zhang, Feng Wang, Rui Wang
JournalJournal of visualized experiments : JoVE (J Vis Exp) Issue 192 (02 03 2023) ISSN: 1940-087X [Electronic] United States
PMID36806629 (Publication Type: Journal Article, Video-Audio Media, Research Support, Non-U.S. Gov't)
Chemical References
  • CD274 protein, human
  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor
  • Gallium Radioisotopes
  • Immune Checkpoint Inhibitors
  • Peptides
Topics
  • Mice
  • Animals
  • B7-H1 Antigen (metabolism)
  • Programmed Cell Death 1 Receptor (metabolism)
  • Gallium Radioisotopes (chemistry)
  • Immune Checkpoint Inhibitors
  • Positron-Emission Tomography (methods)
  • Neoplasms
  • Peptides (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: